| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 09/13/2006 | CN1830476A Nanometer dragon's blood capsule and its preparation method |
| 09/13/2006 | CN1830470A Aerosol and its preparation method |
| 09/13/2006 | CN1830468A Mongoline medicine adhesive paste for treating osteoarthropathy |
| 09/13/2006 | CN1830466A Analgesic medicine and its production method |
| 09/13/2006 | CN1830461A Safflower injection and its preparation method |
| 09/13/2006 | CN1830445A Tropane derivatives having therapy using, compounds and polymorph thereof |
| 09/13/2006 | CN1830443A Preparation method of sophora flavescens freeze dried powder injection |
| 09/13/2006 | CN1830430A Dichlofenas sodium slow release suppository and its preparation method |
| 09/13/2006 | CN1830429A Medicinal chewing tablet used for antipyretic analgesic and its preparation method |
| 09/13/2006 | CN1274713C Inhibitors of kallikrein |
| 09/13/2006 | CN1274690C Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as active ingredient |
| 09/13/2006 | CN1274685C Benzimidazol derivatives modulate che mokine receptors |
| 09/13/2006 | CN1274670C Diaminopropionic acid derivatives |
| 09/13/2006 | CN1274667C Cycloalkenone derivative |
| 09/13/2006 | CN1274306C Pharmaceutical composition comprising gabapentin or an analogue thereof and an alpha-aminoamide and its analgesic use |
| 09/13/2006 | CN1274300C Combination of medication in use for improving dissolution of curcumin and bioavailability as well as preparation method |
| 09/13/2006 | CN1274294C Novel cyclosporin analog microemulsion preconcentrates |
| 09/13/2006 | CN1274293C Ready-to-use paracetamol injection solutions containing propylene glycol as the only cosolvent |
| 09/12/2006 | US7105682 Substituted amine derivatives and methods of use |
| 09/12/2006 | US7105668 Methods and compositions utilizing quinazolinones |
| 09/12/2006 | US7105651 Nucleotide sequences coding polypeptide for use in the treatment of cancer, inflammation and infection; for use as pesticide and antibiotic |
| 09/12/2006 | US7105644 Secreted protein HHTLF25 antibodies |
| 09/12/2006 | US7105641 Immunoglobulin for binding monocyte chemoattractant protein-1(MCP-1) and preventing and/or treating atherosclerosis and cancer ; antitumor agents |
| 09/12/2006 | US7105572 Cardiovascular disorders |
| 09/12/2006 | US7105552 Treatment of inflammation, inflammatory and immunological diseases, insulin resistance, hyperlipidemia, coronary artery disease, cancer and multiple sclerosis. |
| 09/12/2006 | US7105550 2,4-disubstituted thiazolyl derivatives |
| 09/12/2006 | US7105548 Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5 |
| 09/12/2006 | US7105546 Useful for treating or preventing neuronal damage associated with neurological diseases |
| 09/12/2006 | US7105529 A novel compound for treating alopecia induced by cancer chemotherapy or radiotherapy |
| 09/12/2006 | US7105525 6-alkoxy-pyrido-pyrimidines |
| 09/12/2006 | US7105523 Carbamate-substituted pyrazolopyridine-derivatives |
| 09/12/2006 | US7105519 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/12/2006 | US7105508 Integrin receptors antagonists |
| 09/12/2006 | US7105507 Cyclohexane derivatives and their use as therapeutic agents |
| 09/12/2006 | US7105506 For therapy of cardiovascular disorders and erectile dysfunction |
| 09/12/2006 | US7105229 Dispersing a matrix of nanostructured liquid phase or a dehydrated variant and a nanostructured liquid crystalline phase or a dehydrated variant in nonlamellar material; cooling or evaporating a volatile solvent |
| 09/12/2006 | US7105184 Cosmetic and/or dermopharmaceutical preparations containing leaf extracts of the plant Argania spinosa |
| 09/12/2006 | CA2251060C Acylated n-hydroxy methyl thalidomide prodrugs with immunomodulator action |
| 09/08/2006 | WO2006094034A1 Cinnoline compounds and their use as liver x receptor modilators |
| 09/08/2006 | WO2006093336A1 Use of cinnamoyl compound |
| 09/08/2006 | WO2006093313A1 T cell apoptosis inducer |
| 09/08/2006 | WO2006093253A1 Novel cyclic compound having quinolylalkylthio group |
| 09/08/2006 | WO2006093247A1 NOVEL AMINOPYRIDINE COMPOUND WITH Syk INHIBITORY ACTIVITY |
| 09/08/2006 | WO2006092829A1 External plaster containing flurbiprofen |
| 09/08/2006 | WO2006092739A1 Anti-inflammatory conjugates of macrolides and coumarins |
| 09/08/2006 | WO2006092417A1 6 -heteroaryl-1, 2, 3,4,4a, 1ob-hexahydro-phenanthridines as pde-4 inhibitors for the treatment of inflammatory disorders |
| 09/08/2006 | WO2006071548A3 Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases |
| 09/08/2006 | WO2006069293A3 Composition comprising n-acetylcysteine and further pain or anti- inflamm medications |
| 09/08/2006 | WO2006063811A3 Substituted 1,2,4-triazin-5(2h)-ones |
| 09/08/2006 | WO2003028696A8 Compositions for delivery of drug combinations |
| 09/08/2006 | CA2599688A1 Cinnoline compounds and their use as liver x receptor modulators |
| 09/08/2006 | CA2599544A1 Novel aminopyridine compound with syk inhibitory activity |
| 09/08/2006 | CA2598858A1 6 -heteroaryl-1, 2, 3,4,4a, 1ob-hexahydro-phenanthridines as pde-4 inhibitors for the treatment of inflammatory disorders |
| 09/07/2006 | US20060199957 Novel bicyclic and tricyclic cannabinoids |
| 09/07/2006 | US20060199856 Dihydroorotate dehydrogenase (DHODH) inhibitors; Rheumatoid arthritis, Pneumocystis carinii, fibrosis, uveitis, rhinitis, asthma, and athropathy; 2-(Biphenyl-4-ylcarbamoyl)-cyclopent-1-enecarboxylic acid |
| 09/07/2006 | US20060199844 Inhibitors of raf-kinase; Hyperproliferative disorders |
| 09/07/2006 | US20060199835 Neuroprotective and anti-proliferative compounds |
| 09/07/2006 | US20060199827 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/07/2006 | US20060199825 4-Aminating a 4-chloro-2-hydroxy-3-nitrodihydroquinoline with a N-(hetero)cyclylpiperazine, and alkylating the remaining amine group in the quinoline ring to produce a 4-(4-(hetero)cyclylpiperazinyl)-3-nitro-1-alkyldihydroquinolinone |
| 09/07/2006 | US20060199824 Treating or preventing pain, UI, an ulcer, IBD, IBS, an addictive disorder, Parkinson's disease, parkinsonism, anxiety, epilepsy, stroke, a seizure, a pruritic condition, psychosis, a cognitive disorder, a memory deficit, restricted brain function, Huntington's chorea, amyotrophic lateral sclerosis |
| 09/07/2006 | US20060199820 e.g. N1-hydroxy-N2-[(4-phenoxyphenyl)sulfonyl]-D-argininamide; metallopeptidase inhibitor; antiinflammation, anticarcinogenic, antidiabetic agent; angiogenesis inhibitor; atherosclerosis, stroke, ulcer, infertility, scleroderma, endometriosis, mesothelioma |
| 09/07/2006 | US20060199819 Inhibition of cyclooxygenase-2 activity |
| 09/07/2006 | US20060199815 NK1 antagonists |
| 09/07/2006 | US20060199795 e.g. 2-[3,5-trans-5-(3-aminophenyl)-7-chloro-1-neopentyl-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-N-(2-fluorobenzyl)acetamide; G-protein-coupled receptor (TGR5) agonist; central nervous system diseases; antiinflammatory agent; learning enhancement; angina pectoris, arrhythmia, bronchial asthma |
| 09/07/2006 | US20060199792 Peroxynitrite decomposition catalysts and methods of use thereof |
| 09/07/2006 | US20060199787 N-(2-acetamidoethyl)phosphonoformamide; inhibiting effect on zinc-containing proteinases, inhibiting cancer cells |
| 09/07/2006 | US20060198880 Ultraviolet-shielding type patch |
| 09/07/2006 | US20060198846 Combinations for the treatment of diseases involving angiogenesis |
| 09/07/2006 | US20060198826 Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof |
| 09/07/2006 | US20060198821 administering to said individual an effective amount of either i) recombinant protein CD73 or ii) a cytokine or another factor-being capable of inducing endothelial CD73 expression; inflammation |
| 09/07/2006 | DE102005033009A1 Pharmaceutical, dermatological or cosmetic preparation, useful e.g. sun protective cream and cleansing milk, comprises a part of aqueous phase or water of freshly prepared aqueous plant content |
| 09/07/2006 | DE102005009909A1 Verbindungen geeignet zur Beseitigung fehlgefalteter Proteine Compounds suitable for the removal of misfolded proteins |
| 09/06/2006 | EP1698627A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/06/2006 | EP1698624A1 Phenylpropanoic acid derivatives |
| 09/06/2006 | EP1698623A1 Crystal of salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)amino-phenoxy)-7-methoxy-6-quinolinecarboxamide or of solvate thereof and processes for producing these |
| 09/06/2006 | EP1698340A1 T-type calcium channel inhibitor |
| 09/06/2006 | EP1698334A1 Pharmaceutically active isoindoline derivatives |
| 09/06/2006 | EP1698333A1 Fulvic acid and its use in the treatment of viral infections |
| 09/06/2006 | EP1698330A1 Anti-inflammatory analgesic external preparation |
| 09/06/2006 | EP1697362A1 Crf receptor antagonists and methods relating thereto |
| 09/06/2006 | EP1697354A1 Isothiazole dioxides as cxc- and cc- chemokine receptor ligands |
| 09/06/2006 | EP1697346A1 Crystalline form of 2-{ 4-[3-(4-chloro-2-fluorophenyl)-4-pyrimidin-4-yl-1h-pyrazol-5-yl]piperidin-1-yl} -2-oxoethanol |
| 09/06/2006 | EP1697322A1 Substituted tetrahydrocarbazole and cyclopentanoindole derivatives |
| 09/06/2006 | EP1697319A1 Pyrrole compounds |
| 09/06/2006 | EP1696950A2 Vaccine comprising an angiomotin or a polynucleotide encoding an angiomotin and its use for the treatment of angiogenic-related disorders |
| 09/06/2006 | EP1608351B1 Compositions containing superoxide dismutase and a selected et 5-lipoxygenase inhibitor and uses thereof |
| 09/06/2006 | EP1517894B1 N-benzyl-3-phenyl-3-heterocyclyl-propionamide compounds as tachykinin antagonists and/or serotonin reuptake inhibitors |
| 09/06/2006 | EP1423357B1 Urea derivatives with antiproteolytic activity |
| 09/06/2006 | EP1406609B1 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 09/06/2006 | EP1401814B1 Derivatives of 3-phenyl-n-(2- (4-benzyl) piperidin-1-yl)-ethyl)-acrylamid with ccr-3 receptor antagonistic activity for use in the treatment of inflammations and allergic conditions |
| 09/06/2006 | EP1401441A4 Allosteric adenosine receptor modulators |
| 09/06/2006 | EP1349553B1 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain |
| 09/06/2006 | EP1322383B9 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 09/06/2006 | EP1223933B1 5-membered heterocycle derivatives and use thereof as monoaminoxidase inhibitors |
| 09/06/2006 | EP1214350B1 Peptides for combating the autoantibodies that are responsible for dilatative cardiomyopathy (dcm) |
| 09/06/2006 | EP1071449B1 Use of an antagonist antibody to the inflammatory mediator oncostatin m (osm) |
| 09/06/2006 | CN1829712A Nicotinamide derivatives useful as PDE4 inhibitors |
| 09/06/2006 | CN1829711A Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 09/06/2006 | CN1829708A Piperidine compounds and pharmaceutical compositions containing them |
| 09/06/2006 | CN1829694A Quinoline derivates and their use in therapy |